Why are some individuals resistant to the cardioprotective effects of aspirin?: Could it be thromboxane A2?

被引：92

作者：

Halushka, MK

Halushka, PV

机构：

[1] Med Univ S Carolina, Dept Pharmacol, Charleston, SC 29425 USA

[2] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA

[3] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA

来源：

CIRCULATION | 2002年 / 105卷 / 14期

关键词：

editorials; aspirin; thromboxane;

D O I：

10.1161/01.CIR.0000015422.86569.52

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1620 / 1622

页数：3

共 20 条

[1] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
Bombardier, C
Laine, L
Reicin, A
Shapiro, D
Burgos-Vargas, R
Davis, B
Day, R
Ferraz, MB
Hawkey, CJ
Hochberg, MC
Kvien, TK
Schnitzer, TJ
Weaver, A
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) : 1520 - 1528
[2] The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice - Evidence that eicosanoids other than thromboxane contribute to atherosclerosis
Cayatte, AJ
Du, Y
Oliver-Krasinski, J
Lavielle, G
Verbeuren, TJ
Cohen, RA
[J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (07) : 1724 - 1728
[3] Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E2-dependent plaque instability
Cipollone, F
Prontera, C
Pini, B
Marini, M
Fazia, M
De Cesare, D
Iezzi, A
Ucchino, S
Boccoli, G
Saba, V
Chiarelli, F
Cuccurullo, F
Mezzetti, A
[J]. CIRCULATION, 2001, 104 (08) : 921 - 927
[4] Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina
Cipollone, F
Patrignani, P
Greco, A
Panara, MR
Padovano, R
Cuccurullo, F
Patrono, C
Rebuzzi, AG
Liuzzo, G
Quaranta, G
Maseri, A
[J]. CIRCULATION, 1997, 96 (04) : 1109 - 1116
[5] CRAVEN L L, 1953, Miss Valley Med J, V75, P38
[6] DAVISBRUNO KL, 1994, ADV DRUG RES, V25, P173
[7] Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events
Eikelboom, JW
Hirsh, J
Weitz, JI
Johnston, M
Yi, Q
Yusuf, S
[J]. CIRCULATION, 2002, 105 (14) : 1650 - 1655
[8] THROMBOXANES - NEW GROUP OF BIOLOGICALLY-ACTIVE COMPOUNDS DERIVED FROM PROSTAGLANDIN ENDOPEROXIDES
HAMBERG, M
SVENSSON, J
SAMUELSSON, B
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (08) : 2994 - 2998
[9] JAEK DB, 1997, LANCET, V350, P437
[10] Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib
Konstam, MA
Weir, MR
Reicin, A
Shapiro, D
Sperling, RS
Barr, E
Gertz, BJ
[J]. CIRCULATION, 2001, 104 (19) : 2280 - 2288

← 1 2 →